The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.
Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met
We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...
NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....
We are pleased to announce the launch of our new elearning module, Pharmaceutical Management of Neonates: Use of the BABY FLAMINGo! Tool. Designed for pharmacists caring for neonatal patients, this module provides core knowledge to support systematic...
We are delighted to welcome the newest member of the SCRIPT Team, Divya Singh who joins us as a Research Associate. Divya holds a BSc in Biochemistry and a Master of Public Health (MPH) from the University of Birmingham. Before joining SCRIPT, she spent a year at the...